🔎 Trials Near Me

Akèy › Sipwa › Kansas › Wichita

Etid klinik pou Sipwa nan Wichita, KS

8 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Wichita (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Ap rekriteFaz 2
  • AMR Clinical - Wichita, Wichita
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07685808

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3
  • Research Site, Newton · 24 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Ap rekriteFaz 3
  • AMR Clinical, Newton · 24 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07353931

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Ap rekriteFaz 3Volontè an sante akeyi
  • ACCOMPLISH-2 Research Site, Wichita
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Ap rekriteFaz 3
  • Kailera Clinical Site, Newton · 24 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Alliance for Multispecialty Research Newton, Newton · 24 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Ap rekriteFaz 3
  • Alliance for Multispecialty Research LLC, Wichita
  • Alliance for Multispecialty Research Newton, Newton · 24 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684144

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Ap rekriteFaz 3
  • ACCOMPLISH-1 Research Site, Wichita
Laj 18 a 79 · Tout sèks · Mizajou Aug 10, 2026 · NCT07654361

Etid Sipwa nan lòt vil

Lòt etid nan Wichita

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.